Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy
- 5 October 2022
- journal article
- research article
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 30 (2) , 331-341
Abstract
Introduction Super-paramagnetic iron oxide nanoparticles (SPIONs) are known as promising theranostic nano-drug carriers with magnetic resonance imaging (MRI) properties. Applying the herbaceous components with cytotoxic effects as cargos can suggest a new approach in the field of cancer-therapy. In this study mesoporous silica coated SPIONs (mSiO2@SPIONs) containing curcumin (CUR) and silymarin (SIL) were prepared and evaluated on breast cancer cell line, MCF-7. Methods Nanoparticles (NPs) were formulated by reverse microemulsion method and characterized by DLS, SEM and VSM. The in vitro drug release, cellular cytotoxicity, and MRI properties of NPs were determined as well. The cellular uptake of NPs by MCF-7 cells was investigated through LysoTracker Red staining using confocal microscopy. Results The MTT results showed that the IC50 of CUR + SIL loaded mSiO2@SPIONs was reduced about 50% in comparison with that of the free drug mixture. The NPs indicated proper MRI features and cellular uptake through endocytosis. Conclusion In conclusion the prepared formulation may offer a novel theranostic system for breast cancer researches. Graphical abstractKeywords
This publication has 49 references indexed in Scilit:
- Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalizationScientific Reports, 2013
- Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of CancerInternational Journal of Molecular Sciences, 2013
- Curcumin in various cancersBioFactors, 2013
- Silica-based mesoporous nanoparticles for controlled drug deliveryJournal of Tissue Engineering, 2013
- Molecular mechanisms of curcumin action: Gene expressionBioFactors, 2012
- Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cellsInternational Journal of Nanomedicine, 2012
- In vitro release and in vitro–in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticlesInternational Journal of Nanomedicine, 2012
- Highly Aminated Mesoporous Silica Nanoparticles with Cubic Pore StructureJournal of the American Chemical Society, 2010
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug DeliveryACS Nano, 2008
- Ultrafine iron oxide powders generated using a flow-through hydrothermal processMaterials Letters, 1992